journal article·2025-01-01Open access

Narrative review of proximal tubular epithelial cell in-vitro co-culture models

Luka Varda, Tadej Petreski, Lidija Gradišnik, Uroš Maver, Sebastjan Bevc

Biofabrication· Volume 17· Issue 1

Abstract

Abstract Kidney diseases are among the leading causes of death globally. With the increasing rates of acute kidney injury (AKI) requiring hospitalisation, a better understanding of pathophysiological mechanisms is needed to treat the patients more efficiently. Nephrotoxicity is one of the most common causes of AKI, mainly due to the high availability of over-the-counter drugs and natural supplements, which may interact with prescribed drugs at the level of pharmacokinetics, among other factors. The latter can lead to clinically relevant complications (including AKI), which is even more pronounced given the increasingly ageing population in the Western world and the associated increase in polypharmacy. Drug testing starts at the preclinical level, where a reliable model is needed to predict human response to a tested drug with sufficient accuracy. Recently, in-vitro kidney models of different complexities have been created to study various aspects of kidney diseases. Because the proximal tubule plays a vital role in several mechanisms, many models include proximal tubular epithelial cells (PTECs). Monocultures of PTECs do not represent in-vivo tissue accurately enough. Therefore, more complex models with more cell types are being built. To our knowledge, this is the first review focusing on co-culture models and cell types used alongside PTECs for studying the nephrotoxicity of drugs and other mechanisms of AKI and chronic kidney disease.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Epidemiology of end-stage kidney disease10.1053/j.semvascsurg.2021.02.010 ↗
2. Prevalence and disease burden of chronic kidney disease10.1007/978-981-13-8871-2_1. ↗
3. US renal data system 2020 annual data report: epidemiology of kidney disease in the United States10.1053/j.ajkd.2021.01.002 ↗
4. Acute kidney injury epidemiology and causes10.1007/978-3-030-76419-7_8 ↗
5. Global epidemiology and outcomes of acute kidney injury10.1038/s41581-018-0052-0 ↗
6. Nephrotoxic medication exposure in US adults with predialysis chronic kidney disease: health services utilization and cost outcomes10.18553/jmcp.2016.22.8.959 ↗
7. The mechanism of drug nephrotoxicity and the methods for preventing kidney damage10.3390/ijms22116109 ↗
8. Ageing—Demographics
9. Pharmacology behind common drug nephrotoxicities10.2215/CJN.00150118 ↗
10. Contrast-induced nephropathy: a review of mechanisms and risks10.7759/cureus.14842 ↗
11. Medication-induced nephrotoxicity in older patients10.2174/1389200217666160406115959 ↗
12. Polypharmacy, renal insufficiency and elder care: a systematic review10.12968/jokc.2020.5.2.62 ↗
13. Drug-induced nephrotoxicity: pathogenic mechanisms, biomarkers and prevention strategies10.2174/1389200218666171108154419 ↗
14. Drug-induced renal disorders10.12861/jrip.2015.12 ↗
15. Limitations of animal studies for predicting toxicity in clinical trials: is it time to rethink our current approach?10.1016/j.jacbts.2019.10.008 ↗
16. Limitations of animal studies for predicting toxicity in clinical trials: Part 2: potential alternatives to the use of animals in preclinical trials10.1016/j.jacbts.2020.03.010 ↗
17. Drug-induced nephrotoxicity: clinical impact and preclinical in vitro models10.1021/mp400720w ↗
18. Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines10.1124/dmd.107.014902 ↗
19. Species differences in drug transporters and implications for translating preclinical findings to humans10.1517/17425255.2013.741589 ↗
20. Alternative animal and non-animal models for drug discovery and development: bonus or burden?10.1007/s11095-016-2069-z ↗
21. Lost in translation: animal models and clinical trials in cancer treatment
22. Predictive in vivo animal models and translation to clinical trials10.1016/j.drudis.2012.02.003 ↗
23. Brivaracetam: a rational drug discovery success story10.1038/bjp.2008.221 ↗
24. SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy10.1016/j.neuropharm.2007.11.021 ↗
25. Renal proximal tubular epithelial cells: review of isolation, characterization, and culturing techniques10.1007/s11033-020-05977-4 ↗
26. Renal proximal tubular epithelial cells: from harvesting to use in studies10.1159/000531291 ↗
27. Safety biomarker applications in drug development10.2131/jts.44.225 ↗
28. Tissue culture models of AKI: from tubule cells to human kidney organoids10.1681/ASN.2021050693 ↗
29. Interleukin 6 production by human proximal tubular epithelial cells in vitro: analysis of the effects of interleukin-1α (IL-1α) and other cytokines10.1093/ndt/9.6.599 ↗
30. Tomorrow today: organ-on-a-chip advances towards clinically relevant pharmaceutical and medical in vitro models10.1016/j.copbio.2018.08.009 ↗
31. Kidney-on-a-chip technology for drug-induced nephrotoxicity screening10.1016/j.tibtech.2015.11.001 ↗
32. Advances in predictive in vitro models of drug-induced nephrotoxicity10.1038/s41581-018-0003-9 ↗
33. Kidney-on-a-chip: untapped opportunities10.1016/j.kint.2018.06.034 ↗
34. Establishment of renal proximal tubule cell lines derived from the kidney of p53 knockout mice10.1007/s10616-018-0261-1 ↗
35. Role of proximal tubules in the pathogenesis of kidney disease10.1159/000313944 ↗
36. Varda · 2024
37. MDCK (Madin–Darby canine kidney) cells: a tool for membrane permeability screening10.1021/js9803205 ↗
38. The origin and characteristics of a pig kidney cell strain, LLC-PK10.1007/BF02797469 ↗
39. A novel canine kidney cell line model for the evaluation of neoplastic development: karyotype evolution associated with spontaneous immortalization and tumorigenicity10.1007/s10577-015-9474-8 ↗
40. Primary cultures of rat and rabbit renal proximal epithelium as models for nephrotoxicity investigations10.1016/0378-4274(90)90115-3 ↗
41. Renal proximal tubule cell cultures for studying drug-induced nephrotoxicity and modulation of phenotype expression by medium components10.3109/08860229209106645 ↗
42. Differentiated properties characteristic of renal proximal epithelium in a cell line derived from a normal monkey kidney (JTC-12)10.1007/BF02620832 ↗
43. Kidney organoids and tubuloids10.3390/cells9061326 ↗
44. A fibrin-based tissue-engineered renal proximal tubule for bioartificial kidney devices: development, characterization and in vitro transport study10.1155/2013/319476 ↗
45. Development of a microphysiological model of human kidney proximal tubule function10.1016/j.kint.2016.06.011 ↗
46. Tissue-engineered kidney disease models10.1016/j.addr.2013.12.002 ↗
47. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney10.1038/ki.1994.6 ↗
48. Development and application of human renal proximal tubule epithelial cells for assessment of compound toxicity10.2174/2213988501711010019 ↗
49. Cell lines with extended in vitro growth potential from human renal proximal tubule: characterization, response to inducers, and comparison with established cell lines10.1016/S0022-2143(97)90180-3 ↗
50. hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics10.1152/ajprenal.90405.2008 ↗
51. Novel conditionally immortalized human proximal tubule cell line expressing functional influx and efflux transporters10.1007/s00441-009-0882-y ↗
52. A morphological and functional comparison of proximal tubule cell lines established from human urine and kidney tissue10.1016/j.yexcr.2014.02.011 ↗
53. Higher-order kidney organogenesis from pluripotent stem cells10.1016/j.stem.2017.10.011 ↗
54. Regenerating the kidney using human pluripotent stem cells and renal progenitors10.1080/14712598.2018.1492546 ↗
55. Regenerative potential of induced pluripotent stem cells derived from patients undergoing haemodialysis in kidney regeneration10.1038/s41598-018-33256-7 ↗
56. Pluripotent stem cells to rebuild a kidney: the lymph node as a possible developmental niche10.3727/096368915X688632 ↗
57. Three-dimensional cell culture: the missing link in drug discovery10.1016/j.drudis.2012.10.003 ↗
58. Engineered renal tissue as a potential platform for pharmacokinetic and nephrotoxicity testing10.1016/j.drudis.2013.10.023 ↗
59. Tissue culture of human kidney epithelial cells of proximal tubule origin10.1038/ki.1984.28 ↗
60. Characterisation of human tubular cell monolayers as a model of proximal tubular xenobiotic handling10.1016/j.taap.2008.09.018 ↗
61. Advances in 3D cell culture technologies enabling tissue‐like structures to be created in vitro10.1111/joa.12257 ↗
62. An introduction to the third dimension for routine cell culture
63. Paracrine stimulation of human renal fibroblasts by proximal tubule cells10.1046/j.1523-1755.1998.00048.x ↗
64. Engineered vascular beds provide key signals to pancreatic hormone-producing cells10.1371/journal.pone.0040741 ↗
65. The relevance and potential roles of microphysiological systems in biology and medicine10.1177/1535370214542068 ↗
66. Varda · 2024
67. The ultrastructure of the renal interstitium
68. Co-localization of erythropoietin mRNA and ecto-5′-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin10.1177/41.3.8429197 ↗
69. Production of renomedullary prostaglandins by renomedullary interstitial cells grown in tissue culture
70. Renal fibroblast culture10.1159/000020635 ↗
71. Primary culture of human renal proximal tubule epithelial cells and interstitial fibroblasts10.1007/978-1-61779-367-7_12 ↗
72. The origin and role of the renal stroma10.1242/dev.199886 ↗
73. Origin and function of the renal stroma in health and disease10.1007/978-3-319-51436-9_8 ↗
74. Developmental origins and functions of stromal cells in the normal and diseased mammalian kidney10.1002/dvdy.24134 ↗
75. Mechanisms of tubulointerstitial fibrosis10.1681/ASN.2010080793 ↗
76. Cellular and molecular mechanisms of kidney fibrosis10.1016/j.mam.2018.06.002 ↗
77. New insights into the regulation of epithelial–mesenchymal transition and tissue fibrosis10.1016/B978-0-12-394305-7.00004-5 ↗
78. Tubular atrophy in the end-stage kidney: a lectin and immunohistochemical study10.1016/0046-8177(94)90166-X ↗
79. Origin and function of myofibroblasts in kidney fibrosis10.1038/nm.3218 ↗
80. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis10.2353/ajpath.2010.090517 ↗
81. Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis10.1038/nm.3902 ↗
82. Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease10.1038/nm.3901 ↗
83. New insights into the role and mechanism of partial epithelial-mesenchymal transition in kidney fibrosis10.3389/fphys.2020.569322 ↗
84. Varda · 2024
85. Epithelial cells as active player in fibrosis: findings from an in vitro model10.1371/journal.pone.0056575 ↗
86. Proximal tubular cells promote fibrogenesis by TGF-β1–mediated induction of peritubular myofibroblasts10.1046/j.1523-1755.2002.00380.x ↗
87. Tubular overexpression of transforming growth factor-β1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells10.2353/ajpath.2010.091012 ↗
88. Pexicrine effects of basement membrane components on paracrine signaling by renal tubular cells10.1038/ki.1996.7 ↗
89. The impact of the nephrotoxin ochratoxin a on human renal cells studied by a novel co-culture model is influenced by the presence of fibroblasts10.3390/toxins13030219 ↗
90. Ochratoxin A: 50 years of research10.3390/toxins8070191 ↗
91. Identification of a novel lncRNA induced by the nephrotoxin ochratoxin A and expressed in human renal tumor tissue10.1007/s00018-017-2731-6 ↗
92. Monitoring and manipulating cellular crosstalk during kidney fibrosis inside a 3D in vitro co-culture10.1038/s41598-017-12683-y ↗
93. Physiological oxygen and co-culture with human fibroblasts facilitate in vitro-like properties in human renal proximal tubular epithelial cells10.1016/j.cbi.2022.109959 ↗
94. Spontaneous extracellular matrix accumulation in a human in vitro model of renal fibrosis is mediated by αV integrins10.1159/000499506 ↗
95. An immunofluorescence assay for extracellular matrix components highlights the role of epithelial cells in producing a stable, fibrillar extracellular matrix10.1242/bio.025866 ↗
96. Connective tissue growth factor mediates the profibrotic effects of transforming growth factor-β produced by tubular epithelial cells in response to high glucose10.1007/s10157-005-0347-x ↗
97. Tissue-engineered three-dimensional in vitro models for normal and diseased kidney10.1089/ten.tea.2009.0595 ↗
98. Varda · 2024
99. Development of the renal vasculature10.1016/j.semcdb.2018.06.001 ↗
100. Renal endothelial injury and microvascular dysfunction in acute kidney injury10.1016/j.semnephrol.2015.01.010 ↗